Key result
Non-dipper hypertension predicts target organ damage and is linked to ~20% higher cardiovascular mortality.
Why the study?
Non-dipper hypertension is associated with heightened cardiovascular morbidity and mortality, but conventional office measurements often fail to capture nocturnal blood pressure variations.
Non-dipper hypertension is a potent independent predictor of target organ damage and cardiovascular mortality, underscoring the critical role of ambulatory blood pressure monitoring and targeted chronotherapy.
ABPM may identify non-dippers at elevated CV risk in diabetes and obesity; leaves open whether restoring dipping improves outcomes.
Non-dipper hypertension, characterized by a nocturnal blood pressure (BP) decline of less than 10% relative to daytime means, represents a significant clinical phenotype associated with heightened cardiovascular morbidity and mortality. While conventional office measurements often fail to capture these variations, ambulatory blood pressure monitoring (ABPM) has emerged as the gold standard for assessing 24-hour BP variability and identifying circadian rhythm disruptions. This review synthesizes current evidence regarding the clinical profile, pathophysiology, and prognostic impact of the non-dipper pattern. The pathophysiology of non-dipper hypertension involves a complex interplay of autonomic dysregulation, nocturnal renin-angiotensin-aldosterone system hyperactivity, and impaired renal sodium handling. This profile is highly prevalent among patients with metabolic comorbidities, such as type 2 diabetes and obesity, where prevalence rates can reach up to 77%. Prognostically, the non-dipper pattern is a potent independent predictor of target organ damage, including left ventricular hypertrophy, stroke, and chronic kidney disease. Notably, each 5% reduction in nocturnal BP fall is associated with a 20% increase in cardiovascular mortality. Therapeutic management emphasizes personalized chronotherapy specifically bedtime dosing of antihypertensive agents alongside novel pharmacological options like SGLT2 inhibitors and ARNIs. Furthermore, lifestyle interventions such as sodium restriction and the treatment of sleep disorders are crucial for restoring the physiological circadian rhythm. Ultimately, systematic use of ABPM is essential for accurate risk stratification and the implementation of targeted therapies to reduce the global burden of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Szkatuła et al. (2026) conducted a review in Non-dipper hypertension. Non-dipper blood pressure pattern vs. Normal dipper blood pressure pattern was evaluated. Non-dipper hypertension is a potent independent predictor of target organ damage, with each 5% reduction in nocturnal blood pressure fall associated with an approximate 20% increase in cardiovascular mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: